In conclusion, this study demonstrated that miR-302b attenuatedrenal fibrosis by targeting TGF-βR2 to suppress TGF-β/Smad signaling activation.Our findings showed that elevating renal miR-302b levels may be a noveltherapeutic strategy for preventing renal fibrosis. Here, TGFBR2 is linked to fibrosis.